State Street’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $118M | Buy |
1,404,983
+235,784
| +20% | +$19.8M | ﹤0.01% | 1215 |
|
|
2025
Q1 | $83.5M | Sell |
1,169,199
-177,820
| -13% | -$12.7M | ﹤0.01% | 1360 |
|
|
2024
Q4 | $60.5M | Buy |
1,347,019
+204,850
| +18% | +$9.21M | ﹤0.01% | 1631 |
|
|
2024
Q3 | $57.7M | Buy |
1,142,169
+142,033
| +14% | +$7.17M | ﹤0.01% | 1629 |
|
|
2024
Q2 | $40.8M | Buy |
1,000,136
+29,566
| +3% | +$1.21M | ﹤0.01% | 1775 |
|
|
2024
Q1 | $41.5M | Buy |
970,570
+469,168
| +94% | +$20.1M | ﹤0.01% | 1816 |
|
|
2023
Q4 | $20.2M | Buy |
501,402
+485,954
| +3,146% | +$19.6M | ﹤0.01% | 2206 |
|
|
2023
Q3 | $456K | Hold |
15,448
| – | – | ﹤0.01% | 3688 |
|
|
2023
Q2 | $66.3K | Hold |
15,448
| – | – | ﹤0.01% | 4337 |
|
|
2023
Q1 | $33.1K | Hold |
15,448
| – | – | ﹤0.01% | 4607 |
|
|
2022
Q4 | $30.6K | Hold |
15,448
| – | – | ﹤0.01% | 4665 |
|
|
2022
Q3 | $26K | Sell |
15,448
-1
| -0% | -$2 | ﹤0.01% | 4788 |
|
|
2022
Q2 | $43K | Hold |
15,449
| – | – | ﹤0.01% | 4749 |
|
|
2022
Q1 | $52K | Buy |
15,449
+776
| +5% | +$2.61K | ﹤0.01% | 4784 |
|
|
2021
Q4 | $90K | Hold |
14,673
| – | – | ﹤0.01% | 4600 |
|
|
2021
Q3 | $203K | Hold |
14,673
| – | – | ﹤0.01% | 4356 |
|
|
2021
Q2 | $251K | Sell |
14,673
-41,753
| -74% | -$714K | ﹤0.01% | 4129 |
|
|
2021
Q1 | $1.07M | Buy |
56,426
+8,334
| +17% | +$157K | ﹤0.01% | 3612 |
|
|
2020
Q4 | $1.39M | Buy |
48,092
+22,403
| +87% | +$648K | ﹤0.01% | 3490 |
|
|
2020
Q3 | $967K | Buy |
25,689
+5,765
| +29% | +$217K | ﹤0.01% | 3448 |
|
|
2020
Q2 | $663K | Buy |
+19,924
| New | +$663K | ﹤0.01% | 3502 |
|